د. فەرزین ڕەزایی

1- Sustained-release methylphenidate in methamphetamine dependence treatment: a double-blind and placebo-controlled trial; DARU Journal of Pharmaceutical Sciences (2015)

2- Memantine add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: randomized, double-blind, placebo-controlled study; Journal of Clinical Psychopharmacology (2013)

3- Cilostazol adjunctive therapy in treatment of negative symptoms in chronic schizophrenia: Randomized, double-blind, placebo-controlled study; Iranian Clinical Trials Registry (2017)

4- Intranasal Oxytocin as an Adjunct to Risperidone in Patients with Schizophrenia; CNS Drugs (2013)

5– N-Acetylcysteine as an Adjunct to Risperidone for Treatment of Negative Symptoms in Patients With Chronic Schizophrenia; Clinical Neuropharmacology (2013)

6- Double-blind, randomized, placebo-controlled 6-week study on the efficacy and safety of the tamoxifen adjunctive to lithium in acute bipolar mania; Journal of Affective (2011)